Milan, Italy

Leonardo Marsili

This inventor holds 25 USPTO granted patents, primarily in Antibiotic Compounds. Top assignees: Archifar Industrie Chimiche Del Trentino S.p.a., Archifar Laboratori Chimico Farmacologici S.p.a., Rifar S.r.l.. Active years: 1976-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leonardo Marsili. Retrieved from https://idiyas.com/inventor/leonardo-marsili

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 6

Forward Citations = 107(Granted Patents)


Location History:

  • Segrate, (Milan), IT (1977)
  • Milan, IT (1976 - 1990)
  • Segrate, IT (1981 - 1994)

Company Filing History:


Years Active: 1976-1994

Loading Chart...
Areas of Expertise:
Cefadroxil
Rifamycin
Antibiotic Activity
Crystalline Compounds
Solvates
Derivatives
3-Azinomethyl
Ansamycins
Preparation Methods
Hemihydrate
Monohydrate
High Activity
25 patents (USPTO):Explore Patents

Title: Leonardo Marsili: Innovating in Pharmaceutical Sciences

Introduction

Leonardo Marsili, based in Milan, Italy, is a notable inventor with a substantial contribution to the field of pharmaceutical sciences. With 25 patents to his name, Marsili has demonstrated a relentless pursuit of innovation, particularly in the development of novel forms of cefadroxil, a widely used antibiotic.

Latest Patents

Among his latest inventions, Marsili has developed a method for producing a substantially anhydrous crystalline cefadroxil. This innovative formulation boasts a water content ranging from approximately 0.8% to 3.9%. The process involves slurrying a cefadroxil solvate, utilizing solvents such as dimethylacetamide, N-methyl-2-pyrrolidone, or monomethylformamide, along with isopropyl alcohol. This mixture may contain up to 4% water and is often produced with methanol present in a quantity less than 60%, under controlled temperatures of 45 to 55 degrees Celsius.

Additionally, he has created a novel crystalline cefadroxil hemihydrate, characterized by stability and a K.F. value between 3.5 and 2.0%. This new compound is obtained through the preparation and isolation of a cefadroxil solvate and involves slurrying with a methanol/isopropyl alcohol mixture in a specific ratio. This innovative work contributes significant advancements to the pharmaceutical formulation sector.

Career Highlights

Throughout his career, Leonardo Marsili has been affiliated with esteemed organizations such as Archifar Laboratori Chimico Farmacologici S.p.a. and Archifar Industrie Chimiche Del Trentino S.p.a. His experience at these companies underscores his expertise in pharmaceutical research and product development, cementing his reputation as a leading inventor in the industry.

Collaborations

In his pursuit of innovation, Marsili has collaborated with notable colleagues, including Carmine Pasqualucci and Vittorio Rossetti. These partnerships have fostered a dynamic environment for brainstorming and advancing pharmaceutical technologies, driving the improvement of existing formulations and the creation of new therapeutic agents.

Conclusion

Leonardo Marsili's dedication to innovation in the pharmaceutical field, particularly through his advancements in cefadroxil compounds, exemplifies the importance of research and development in healthcare. His impressive portfolio of 25 patents reflects his commitment to improving drug stability and effectiveness, while his collaborations highlight the value of teamwork in achieving groundbreaking results. As he continues to push the boundaries of pharmaceutical science, Marsili remains a vital contributor to the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…